Maternal intrahepatic cholestasis disrupts neonatal fatty acid β-oxidation in term neonates: metabolomic profiling from a retrospective cohort

Background Intrahepatic cholestasis of pregnancy (ICP) impacts perinatal outcomes and is associated with long-term metabolic disorders in offspring, although the mechanisms are not fully understood. On the basis of the developmental origins of health and disease hypothesis, maternal metabolic disturbances may permanently modify the metabolic pathways of offspring through intrauterine alterations. Nevertheless, the specific role of ICP in this process remains unclear. Methods We analyzed a cohort of 30 neonates born to mothers with ICP and 73 controls from the Sixth Affiliated Hospital of Sun Yat-sen University (2017–2023). Blood amino acids and acylcarnitines were quantified via liquid chromatography‒tandem mass spectrometry. Orthogonal partial least squares-discriminant analysis identified differentially abundant metabolites. Metabolic pathway analysis was conducted via MetaboAnalyst 6.0. A binary logistic regression model was used to evaluate diagnostic performance via receiver operating characteristic (ROC) curves. Results Neonates exposed to ICP demonstrated significant metabolic alterations, involving 10 acylcarnitines and 6 amino acids. Pathway analysis revealed disruptions in the mitochondrial β -oxidation of fatty acids, the urea cycle, and aspartate metabolism. A diagnostic model combining six metabolites achieved high accuracy (AUC: 0.986, 95% CI: 0.941–1.000). The C18:1-OH/C10 ratio was correlated with maternal bile acid levels ( r = 0.47, P < 0.05) and showed diagnostic potential (AUC = 0.923, 95% CI: 0.854–0.966). Conclusion This study is the first to suggest that ICP disrupts neonatal metabolic programming through bile acid-mediated suppression of fatty acid β -oxidation. The C18:1-OH/C10 ratio serves as a biomarker for maternal–fetal metabolic crosstalk, offering a potential target for early interventions.

Authors

Institutions

Publication Details

Journal
Frontiers in Pediatrics
Published
2026-11-16
DOI
https://doi.org/10.3389/fped.2026.1917603
Primary Topic
Birth, Development, and Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Maternal intrahepatic cholestasis disrupts neonatal fatty acid β-oxidation in term neonates: metabolomic profiling from a retrospective cohort

郝虎, Mengxian Liu, Sitao Li, Chuqin Lin et al.
3 links
Frontiers in Pediatrics
Birth, Development, and Health
article

Maternal intrahepatic cholestasis disrupts neonatal fatty acid β-oxidation in term neonates: metabolomic profiling from a retrospective cohort

郝虎, Mengxian Liu, Sitao Li, Chuqin Lin, Xin Xiao, Zhirong Deng, Xia Gu, Bingqing Liu
article en

Abstract

Background Intrahepatic cholestasis of pregnancy (ICP) impacts perinatal outcomes and is associated with long-term metabolic disorders in offspring, although the mechanisms are not fully understood. On the basis of the developmental origins of health and disease hypothesis, maternal metabolic disturbances may permanently modify the metabolic pathways of offspring through intrauterine alterations. Nevertheless, the specific role of ICP in this process remains unclear. Methods We analyzed a cohort of 30 neonates born to mothers with ICP and 73 controls from the Sixth Affiliated Hospital of Sun Yat-sen University (2017–2023). Blood amino acids and acylcarnitines were quantified via liquid chromatography‒tandem mass spectrometry. Orthogonal partial least squares-discriminant analysis identified differentially abundant metabolites. Metabolic pathway analysis was conducted via MetaboAnalyst 6.0. A binary logistic regression model was used to evaluate diagnostic performance via receiver operating characteristic (ROC) curves. Results Neonates exposed to ICP demonstrated significant metabolic alterations, involving 10 acylcarnitines and 6 amino acids. Pathway analysis revealed disruptions in the mitochondrial β -oxidation of fatty acids, the urea cycle, and aspartate metabolism. A diagnostic model combining six metabolites achieved high accuracy (AUC: 0.986, 95% CI: 0.941–1.000). The C18:1-OH/C10 ratio was correlated with maternal bile acid levels ( r = 0.47, P < 0.05) and showed diagnostic potential (AUC = 0.923, 95% CI: 0.854–0.966). Conclusion This study is the first to suggest that ICP disrupts neonatal metabolic programming through bile acid-mediated suppression of fatty acid β -oxidation. The C18:1-OH/C10 ratio serves as a biomarker for maternal–fetal metabolic crosstalk, offering a potential target for early interventions.

Frontiers in PediatricsVol. 14
Sun Yat-sen University (CN), Sixth Affiliated Hospital of Sun Yat-sen University (CN)
Good health and well-being
Birth, Development, and Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon